Clene Nanomedicine

Salt Lake City, United States

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

May 2026

Post-IPO Equity

Biotechnology Health Care Medical Pharmaceutical

Top Investors

Vivo CapitalNational Institutes of HealthCoastlands CapitalBoxer CapitalNational Multiple Sclerosis Society (NMSS)

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Clene Nanomedicine

Who are Clene Nanomedicine's investors?

Clene Nanomedicine's investors include Vivo Capital, National Institutes of Health, Coastlands Capital, Boxer Capital, National Multiple Sclerosis Society (NMSS).

Where is Clene Nanomedicine headquartered?

Clene Nanomedicine is headquartered in Salt Lake City, United States.

What does Clene Nanomedicine do?

Clene Nanomedicine focuses on the development of unique therapeutics for neurodegenerative diseases.

What stage is Clene Nanomedicine at?

Clene Nanomedicine is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated May 5, 2026.

MLA

"Clene Nanomedicine — Funding & Investors." VCBacked, May 5, 2026, https://www.vcbacked.co/company/clene-nanomedicine. Accessed June 3, 2026.

APA

VCBacked. (2026). Clene Nanomedicine — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/clene-nanomedicine

Wikipedia (cite web)

{{cite web |title=Clene Nanomedicine — Funding & Investors |url=https://www.vcbacked.co/company/clene-nanomedicine |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated May 5, 2026.